Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 1.20% is 122% above its 5-year average of -5.49%, near the high end of its 5-year range (-14.57%–3.15%).
6.33% below its 12-month average of 1.28%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.15%.
OPERATING MARGIN
1.20%
OPERATING MARGIN AVG TTM
1.28%
OPERATING MARGIN AVG 3Y
-2.31%
OPERATING MARGIN AVG 5Y
-5.49%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.33%
CURRENT VS 3Y AVG
+151.85%
CURRENT VS 5Y AVG
+121.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.71B
Operating Margin
1.20%
TTM Avg
1.28%
3Y Avg
-2.31%
5Y Avg
-5.49%
Market Cap
$1.73B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.68B
Operating Margin
-134.48%
TTM Avg
-159.75%
3Y Avg
-419.83%
5Y Avg
-335.87%
Market Cap
$1.75B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
Market Cap
$1.66B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
Market Cap
$1.65B
Operating Margin
15.35%
TTM Avg
4.65%
3Y Avg
1.95%
5Y Avg
-3.05%
Market Cap
$1.81B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.83B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
Market Cap
$1.85B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.71B | 1.20% | 1.28% | -2.31% | -5.49% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 11.69% | -8.16% | -10.59% | -4.68% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.68B | -134.48% | -159.75% | -419.83% | -335.87% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.75B | -737.04% | -849.82% | -849.82% | -849.82% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -5.55% | -16.51% | -27.71% | -34.02% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 15.35% | 4.65% | 1.95% | -3.05% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.81B | -651.67% | -787.38% | -968.58% | -820.03% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 29.46% | 25.49% | 21.64% | 22.06% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 2.61% | 3.43% | 5.52% | 6.07% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
Gross Margin
12.6%
Operating Margin
1.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.15% |
| 2026-03-31 | 1.26% |
| 2025-12-31 | -1.02% |
| 2025-09-30 | 0.77% |
| 2025-06-30 | 2.24% |
| 2025-03-31 | -0.58% |
| 2024-12-31 | -3.22% |
| 2024-09-30 | -2.82% |
| 2024-06-30 | -2.70% |
| 2024-03-31 | -6.54% |
| 2023-12-31 | -9.01% |
| 2023-09-30 | -6.52% |
| 2023-06-30 | -5.12% |
| 2023-03-31 | -7.40% |
| 2022-12-31 | -14.40% |
| 2022-09-30 | -9.27% |
| 2022-06-30 | -1.81% |
| 2022-03-31 | -10.56% |
| 2021-12-31 | -14.57% |
| 2021-09-30 | -14.12% |
| 2021-06-30 | -13.11% |
| 2021-03-31 | -19.72% |
| 2020-12-31 | -11.47% |
| 2020-09-30 | 6.08% |
| 2020-06-30 | 5.15% |
| 2020-03-31 | -2.28% |
